Effect of High Dose Verapamil on Restenosis After Peripheral Angioplasty 11Financial support for this study was provided by Knoll Deutschland GmbH, Berlin, Germany.

Schweizer, Johannes; Kirch, Wilhelm; Koch, Rainer; Hellner, Grit; Uhlmann, K

doi:10.1016/s0735-1097(98)00100-4

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Effect of High Dose Verapamil on Restenosis After Peripheral Angioplasty 11Financial support for this study was provided by Knoll Deutschland GmbH, Berlin, Germany.

Abstract: In patients with POAD at increased risk for restenosis, the administration of high dose verapamil prevented recurrent stenosis for 6 months after successful peripheral angioplasty and was well tolerated.

Cited by 17 publications

References 30 publications

Treatment of hypertension in peripheral arterial disease

Treatment of hypertension in peripheral arterial disease

Treatment of hypertension in peripheral arterial disease

Treatment of hypertension in peripheral arterial disease

Contact Info

Product

Resources

About